Effectiveness and Safety of Very Low Dose Combined Oral Contraceptive for the Treatment of Non-atypical Endometrial Hyperplasia: A Pilot Study
Objective: A randomized control study to compare the effectiveness and the safety of very low dose oral contraceptive (OC) with progestin for the treatment of endometrial hyperplasia. Methods: Ten patients with non-atypical endometrial hyperplasia who did not have contraindications for OC were rand...
Main Authors: | Pichai Leerasiri, Manee Rattanachaiyanont, Surasak Angsuwathana, Kitirat Techatraisak, Prasong Tanmahasamut, Suchada Tanphatthana |
---|---|
Format: | Article |
Language: | English |
Published: |
Mahidol University
2006-05-01
|
Series: | Siriraj Medical Journal |
Subjects: | |
Online Access: | https://he02.tci-thaijo.org/index.php/sirirajmedj/article/view/245823 |
Similar Items
-
Aromatase inhibitor “letrozole” versus progestin “norethisterone” in women with simple endometrial hyperplasia without atypia: A prospective cohort trial
by: M. El-shamy, et al.
Published: (2012-06-01) -
Gynecological Endocrinology Patients Attending Siriraj Hospital at the Beginning of the New Millennium
by: Kitirat Techatraisak, et al.
Published: (2007-11-01) -
Prominent decidualization following progestin treatment for endometrial hyperplasia and carcinoma as a mimic of large residual tumor: A cautionary tale
by: Yang Hu, et al.
Published: (2021-05-01) -
Progestin Intrauterine Devices and Metformin: Endometrial Hyperplasia and Early Stage Endometrial Cancer Medical Management
by: Oroma Nwanodi
Published: (2017-07-01) -
Results of surgical treatment of atypical endometrial hyperplasia
by: O. A. Gornykh, et al.
Published: (2014-07-01)